CMS certification 230222
Mymichigan Medical Center Midland
4000 Wellness Drive, Midland, MI 48670
Mymichigan Medical Center Midland has a CMS overall rating of 4 out of 5 stars. 80% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 26 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on 1. Emergency patients spend a median of 2 h 33 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 765 completed surveys, 42% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | MI | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 417 visits sampled · US median for EDs of the same volume: 3 h 21 min | 2 h 33 min | 2 h 39 min | 2 h 42 min |
| Left before being seen Lower is better · 69,322 patients | 2% | 3% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 17 patients | 76% | 72% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 166 patients | 64% | 60% | 65% |
How Mymichigan Medical Center Midland compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Mymichigan Medical Center MidlandThis hospital | 4/5 | 80% | 2 h 33 min | 3 better 1 worse |
| Mymichigan Medical Center West BranchSame ZIP area · West Branch | 5/5 | 78% | 3 h 13 min | No different |
| Saint Mary's Standish Community HospitalSame ZIP area · Standish | 4/5 | 86% | 1 h 40 min | No different |
| Mymichigan Medical Center GladwinSame ZIP area · Gladwin | Not rated | 81% | 2 h 13 min | No different |
| Mymichigan Medical Center ClareSame ZIP area · Clare | 2/5 | 72% | 2 h 32 min | No different |
| Covenant Medical CenterSame ZIP area · Saginaw | 2/5 | 71% | 3 h 18 min | 2 better 4 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 4,521 cases | Too few cases | 4.6% | 3.9% |
| Heart attack 277 cases | Too few cases | 12.1% | 11.9% |
| Heart failure 404 cases | Too few cases | 10.6% | 11.1% |
| Pneumonia 421 cases | Too few cases | 19.1% | 15.2% |
| Stroke 425 cases | Too few cases | 13% | 11.9% |
| COPD 142 cases | Too few cases | 7.7% | 8.6% |
| Heart bypass surgery (CABG) 41 cases | Too few cases | 2.7% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.14 likely 0.83 – 1.45 | 1 |
| After hip or knee replacement 139 cases | Too few cases | 2.9% | 4.1% |
| Deaths after a serious but treatable surgical complication 100 cases | No different | 214.84 per 1,000 likely 169.44 per 1,000 – 260.23 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 5,018 cases | No different | 0.86 per 1,000 likely 0.21 per 1,000 – 1.52 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 6,159 cases | No different | 0.14 per 1,000 likely 0 per 1,000 – 0.33 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 6,292 cases | No different | 0.26 per 1,000 likely 0.06 per 1,000 – 0.45 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,561 cases | No different | 2.87 per 1,000 likely 1.46 per 1,000 – 4.28 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 605 cases | No different | 1.77 per 1,000 likely 0.19 per 1,000 – 3.34 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 598 cases | No different | 13.79 per 1,000 likely 7.24 per 1,000 – 20.33 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 1,623 cases | No different | 3.65 per 1,000 likely 1.61 per 1,000 – 5.7 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 604 cases | No different | 3.63 per 1,000 likely 0.02 per 1,000 – 7.25 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 253 cases | No different | 1.9 per 1,000 likely 0.45 per 1,000 – 3.35 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,147 cases | No different | 1.42 per 1,000 likely 0.49 per 1,000 – 2.36 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.94 likely 0.41 – 1.86 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.4 likely 0.16 – 0.83 | 1 |
| Surgical site infections after colon surgery | Better | 0.18 likely 0.01 – 0.88 | 1 |
| MRSA bloodstream infections | No different | 0.55 likely 0.09 – 1.81 | 1 |
| C. diff intestinal infections | Better | 0.17 likely 0.07 – 0.33 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 526 cases | Too few cases | 13.3% | 14.4% |
| Readmitted after heart failure 840 cases | Too few cases | 20.2% | 21.3% |
| Readmitted after pneumonia 849 cases | Too few cases | 18.2% | 17.3% |
| Readmitted after COPD 303 cases | Too few cases | 18.4% | 20% |
| Readmitted after heart bypass surgery 93 cases | Too few cases | 9.3% | 11% |
| Readmitted after hip or knee replacement 127 cases | Too few cases | 5.4% | 5.8% |
| Days back in hospital after a heart attack 287 cases | Too few cases | 2.8 days per 100 | — |
| Days back in hospital after heart failure 453 cases | Too few cases | -8.8 days per 100 | — |
| Days back in hospital after pneumonia 431 cases | Too few cases | 24.4 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 667 cases | No different | 12.8 per 1,000 likely 9.6 per 1,000 – 16.8 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 50 cases | No different | 10.4 per 100 likely 6.9 per 100 – 15.3 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 50 cases | No different | 5.2 per 100 likely 3.2 per 100 – 8.2 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 851 cases | No different | 1 likely 0.8 – 1.3 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
148 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 22 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Internal Medicine | 25 |
| Nurse Anesthetist, Certified Registered | 14 |
| Anesthesiology | 12 |
| Family | 11 |
| Physician Assistant | 10 |
| Family Medicine | 8 |
| Pharmacist | 5 |
| Registered Nurse | 5 |
| Speech-Language Pathologist | 5 |
| Critical Care Medicine | 4 |
| Diagnostic Radiology | 4 |
| Nurse Practitioner | 4 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $244,600
- 2020 $240,156
- 2021 $170,332
- 2022 $306,983
- 2023 $519,075
- 2024 $681,428
- 2025 $596,046
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Speaking, teaching and other services | $14,625 | 28 |
| Space rental and facility fees | $2,200 | 2 |
| Medical devices and supplies on long-term loan | $1,425 | 1 |
| Debt forgiveness | $780 | 2 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Novartis Pharmaceuticals Corporation | $392,268 | 8 |
| Abbott Laboratories | $81,339 | 9 |
| Regeneron Pharmaceuticals, Inc. | $45,086 | 9 |
| Dompe Farmaceutici S.p.A. | $40,326 | 17 |
| Stryker Corporation | $15,466 | 3 |
| Tandem Diabetes Care, Inc. | $13,100 | 22 |
| AstraZeneca Pharmaceuticals LP | $5,156 | 1 |
| Medtronic, Inc. | $1,525 | 6 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Even… Novartis Pharmaceuticals Corporation | $286,403 |
| NCT05932615--ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation Abbott Laboratories | $81,339 |
| Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Partici… Novartis Pharmaceuticals Corporation | $51,031 |
| A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSC… Regeneron Pharmaceuticals, Inc. · NCT06585410 | $45,086 |
| Evaluation of Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Corona… Novartis Pharmaceuticals Corporation | $27,325 |
| A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Pelacarsen (TQJ230) With Back… Novartis Pharmaceuticals Corporation | $26,309 |
| Phase 2, proof-of-concept, randomized, double-blinded, placebo-controlled, multicenter study to assess efficacy and safety of reparixin as add-on th… Dompe Farmaceutici S.p.A. | $20,395 |
| Reparixin 1200 mg three times a day as add-on therapy to standard of care to limit disease progression in hospitalised adult patients with COVID-19 a… Dompe Farmaceutici S.p.A. | $19,932 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Mymichigan Medical Center Midland
Is Mymichigan Medical Center Midland a good hospital?
Mymichigan Medical Center Midland has a CMS overall rating of 4 out of 5 stars. Of the 26 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on 1. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Mymichigan Medical Center Midland?
80% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 765 completed HCAHPS surveys.
How long is the wait in the Mymichigan Medical Center Midland emergency room?
Emergency patients spend a median of 2 h 33 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 2% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Mymichigan Medical Center Midland receive money from drug and device companies?
Drug and device makers reported $596,046 in payments to Mymichigan Medical Center Midland for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.